Showing results (181-190 of 313) with videos related to

Sort By:
Pageof 32
Addiction Biology|March 19, 2013
Age-related differences in working memory deficits during nicotine withdrawalMary Falcone, E Paul Wileyto, Kosha Ruparel, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 23, 2005
Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropionE Paul Wileyto, Freda Patterson, Raymond Niaura, et al.
Addiction Biology|April 22, 2011
Brain activity and emotional processing in smokers treated with vareniclineJames Loughead, Riju Ray, E Paul Wileyto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 2, 2013
The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sexAndy Z X Zhu, Caroline C Renner, Dorothy K Hatsukami, et al.
Obesity (Silver Spring, Md.)|December 1, 2006
No evidence for a major role of polymorphisms during bupropion treatmentJianfang Hu, David T Redden, Wade H Berrettini, et al.
Behavioural Pharmacology|August 12, 2008
Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative moodKenneth A Perkins, Caryn Lerman, Amy Grottenthaler, et al.
Nuclear Medicine Communications|February 27, 2009
Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agentAndrew B Newberg, Riju Ray, Joshua Scheuermann, et al.
American Journal of Medical Genetics. Part A|January 6, 2005
BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationshipsAideen McInerney-Leo, Barbara Bowles Biesecker, Donald W Hadley, et al.
Biological Psychiatry|October 10, 2008
Varenicline improves mood and cognition during smoking abstinenceFreda Patterson, Christopher Jepson, Andrew A Strasser, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2014
Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokersMeghan J Chenoweth, Maria Novalen, Larry W Hawk, et al.
Pageof 32